Bardy’s presentation, “The importance of P-Wave centric ECG monitoring analysis,” highlighted the significance of high-fidelity ECG tracings in accurate arrhythmia diagnosis and treatment decisions. As part of the AF Association Symposia’s “Management of Atrial Fibrillation” Session, Dr. Bardy, MD was invited to speak at Heart Rhythm Congress (HRC) 2019 held at The International Convention Centre in Birmingham, UK. In addition, BardyDx Founder and Chief Executive Officer, Gust H. “We are committed to providing optimal P-wave focused digital health solutions that inform the modern-day cardiology practice.”
BARDY DIAGNOSTICS PATCH
“It is an honor for the CAM patch to be chosen and recognized as one of the best remote cardiac monitoring solutions from among those presenting by an audience of pioneering cardiac physicians and industry thought leaders,” said Ken Nelson, BardyDx Chief Commercial Officer and pitch session presenter. Over a dozen pitch session events provided selected applicants the opportunity to present on their digital health technology, including categories in artificial intelligence, m-health, wearables, and remote monitoring. The pitch event was held on the Digital Health Stage as part of ESC’s focus on highlighting innovative technological applications in the field of e-cardiology and how they are impacting research and clinical practice, including wearable devices, mobile apps, electronic health records, and big data. The data presented on this page does not represent the view of Bardy Diagnostics and its employees or that of Zippia.īardy Diagnostics may also be known as or be related to Bardy Diagnostics, Bardy Diagnostics Inc and Bardy Diagnostics, Inc.SEATTLE, Oct. 24, 2019 /PRNewswire/ - Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected as winner of the “Remote Monitoring in Arrhythmias” Technology and Innovation Pitch Session held as part of the Digital Health program at the European Society of Cardiology (ESC) Congress 2019. BardyDx earned this distinction for its Carnation Ambulatory Monitor (CAM™), the only P-wave centric™ ambulatory cardiac patch monitoring and arrhythmia detection device. None of the information on this page has been provided or approved by Bardy Diagnostics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies.
The employee data is based on information from people who have self-reported their past or current employments at Bardy Diagnostics. Zippia gives an in-depth look into the details of Bardy Diagnostics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bardy Diagnostics.
0 kommentar(er)
